Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01398319 · ClinicalTrials.gov registry record · NA
Prevention of Alcohol Related Incidents in the US Air Force
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 26,231
- Enrollment target
NCT01398319: Completed NA study, sponsored by University of Virginia.
NCT01398319 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 26,231 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1770% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01398319, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 26,231 participants
- Enrollment target
Study Summary
Alcohol misuse poses significant public health concerns in the U.S. military. A Brief Alcohol Intervention (BAI) have been shown to reduce alcohol related incidents among Airmen undergoing training. The current study sought to examine whether a booster BAI administered at the end of an Airmen's training reduced alcohol related incidents out to a one-year follow-up. Participants were 26,231 US Air Force Technical Trainees recruited between March 2016 and July 2018. Participants were cluster randomized by cohort to two conditions: BAI + BAI Booster or BAI + Bystander Intervention. The primary analysis was a comparison of the interventions' efficacies in preventing Article 15 alcohol related incidents at a one-year follow-up, conducted using a generalized estimating equations logistic regression model controlling for covariates.
Primary Outcome
Adjudicated alcohol related incident in the United States Air Force (Article 15). We determined if an Airmen had received an Article 15 in the year following Technical Training by searching the Automated Military Justice Analysis and Management System (AMJAMS).
Interventions
- BEHAVIORAL Group Brief Alcohol Intervention
- BEHAVIORAL Group Brief Alcohol Intervention Booster
- BEHAVIORAL Bystander Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,231 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2018-07-31 |
| Phase | NA |
What the finished NCT01398319 record still lists
NCT01398319 is an interventional study that assigns participants to a tested intervention. Its 26,231 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1770% higher).
The record links to 0 conditions, and to 3 interventions - of which Group Brief Alcohol Intervention is the first listed.
NCT01398319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01398319 about?
NCT01398319 is a clinical study titled "Prevention of Alcohol Related Incidents in the US Air Force". Alcohol misuse poses significant public health concerns in the U.S. military. A Brief Alcohol Intervention (BAI) have been shown to reduce alcohol related incidents among Airmen undergoing training. The current study sought to examine whether a booster BAI administered at the end of an Airmen's trai...
What is the current status of trial NCT01398319?
This trial is currently completed. It is a NA study. The enrollment target is 26,231 participants. The study started on 2016-03-01. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT01398319?
The interventions under investigation include: Group Brief Alcohol Intervention (BEHAVIORAL), Group Brief Alcohol Intervention Booster (BEHAVIORAL), Bystander Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01398319?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01398319's enrollment target sits among peer trials
26,231 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI